Journal Title
Frontiers in Pharmacology

FRONT PHARMACOL

ISSN / eISSN
1663-9812
Aims and Scope
Frontiers in Pharmacology is a leading journal in its field, publishing rigorously peer-reviewed research across disciplines, including basic and clinical pharmacology, medicinal chemistry, pharmacy and toxicology. Field Chief Editor Heike Wulff at UC Davis is supported by an outstanding Editorial Board of international researchers. This multidisciplinary open-access journal is at the forefront of disseminating and communicating scientific knowledge and impactful discoveries to researchers, academics, clinicians and the public worldwide.
Subject Area

PHARMACOLOGY & PHARMACY

CiteScore
6.30 View Trend
CiteScore Ranking
Category Quartile Rank
Medicine - Pharmacology (medical) Q1 #55/260
Medicine - Pharmacology Q2 #101/301
Web of Science Core Collection
Science Citation Index Expanded (SCIE) Social Sciences Citation Index (SSCI)
Indexed -
Category (Journal Citation Reports 2023) Quartile
PHARMACOLOGY & PHARMACY - SCIE Q1
H-index
62
Country/Area of Publication
SWITZERLAND
Publisher
Frontiers Media S.A.
Annual Article Volume
5377
Open Access
YES
Contact
AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, SWITZERLAND, CH-1015
Verified Reviews
Note: Verified reviews are sourced from across review platforms and social media globally.
The first review was actually very fast, taking only half a month. However, there was a conflict of opinions between the two reviewers. It took a long time to invite the third reviewer. After urging for the submission once in the fourth month, I learned about the invitation of the third reviewer. Then I quickly received the third reviewer's acceptance of the comments. Overall, the editors of Frontiers in Pharmacology prioritize innovation and do not have strict requirements on workload. The second reviewer believed that the workload of the manuscript was too low and rejected it by casually mentioning a few shortcomings in innovation. Although there is no requirement to respond to rejection comments, I still wrote an email addressing each of the issues raised by reviewer 2. The editor has a discerning eye and can identify the highlights of the article, not influenced by individual reviewers' opinions, and agreed to accept it. I think the quality of this journal is still very high. Currently, this journal is classified as a top pharmaceutical journal in the Chinese Academy of Sciences, so it is worth submitting to.
2022-03-22
Mid-January submission
End of January external review begins
End of February, three reviewers' comments returned
End of March, beginning of April, second review completed
Early April, editing and proofreading
April 15th, acceptance
Exactly three months from submission to acceptance. The assigned editor's efficiency was very high. One reviewer made straightforward comments during the first review, while the other two provided minor suggestions for revision. The second review pointed out some detail issues, but after making the necessary revisions, all three reviewers quickly approved. The editing and proofreading stage focused on formatting and writing errors, which were fixed and accepted on the same day. Overall, the submission process went smoothly.
2021-04-16

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started